175 related articles for article (PubMed ID: 1851551)
1. BEK and FLG, two receptors to members of the FGF family, are amplified in subsets of human breast cancers.
Adnane J; Gaudray P; Dionne CA; Crumley G; Jaye M; Schlessinger J; Jeanteur P; Birnbaum D; Theillet C
Oncogene; 1991 Apr; 6(4):659-63. PubMed ID: 1851551
[TBL] [Abstract][Full Text] [Related]
2. The amplification unit on chromosome 11q13 in aggressive primary human breast tumors entails the bcl-1, int-2 and hst loci.
Ali IU; Merlo G; Callahan R; Lidereau R
Oncogene; 1989 Jan; 4(1):89-92. PubMed ID: 2915903
[TBL] [Abstract][Full Text] [Related]
3. Proto-oncogene amplification and human breast tumor phenotype.
Adnane J; Gaudray P; Simon MP; Simony-Lafontaine J; Jeanteur P; Theillet C
Oncogene; 1989 Nov; 4(11):1389-95. PubMed ID: 2554239
[TBL] [Abstract][Full Text] [Related]
4. Flg-2, a new member of the family of fibroblast growth factor receptors.
Avivi A; Zimmer Y; Yayon A; Yarden Y; Givol D
Oncogene; 1991 Jun; 6(6):1089-92. PubMed ID: 1648703
[TBL] [Abstract][Full Text] [Related]
5. Chromosome 11q13, c-erbB-2, and c-myc amplification in invasive breast carcinoma: clinicopathologic correlations.
Gaffey MJ; Frierson HF; Williams ME
Mod Pathol; 1993 Nov; 6(6):654-9. PubMed ID: 7905628
[TBL] [Abstract][Full Text] [Related]
6. Sporadic amplification of the insulin-like growth factor 1 receptor gene in human breast tumors.
Berns EM; Klijn JG; van Staveren IL; Portengen H; Foekens JA
Cancer Res; 1992 Feb; 52(4):1036-9. PubMed ID: 1310636
[TBL] [Abstract][Full Text] [Related]
7. Amplification of FGF-related genes in human tumors: possible involvement of HST in breast carcinomas.
Theillet C; Le Roy X; De Lapeyrière O; Grosgeorges J; Adnane J; Raynaud SD; Simony-Lafontaine J; Goldfarb M; Escot C; Birnbaum D
Oncogene; 1989 Jul; 4(7):915-22. PubMed ID: 2474139
[TBL] [Abstract][Full Text] [Related]
8. Genetic alterations of c-myc, c-erbB-2, and c-Ha-ras protooncogenes and clinical associations in human breast carcinomas.
Garcia I; Dietrich PY; Aapro M; Vauthier G; Vadas L; Engel E
Cancer Res; 1989 Dec; 49(23):6675-9. PubMed ID: 2573420
[TBL] [Abstract][Full Text] [Related]
9. GST pi gene is frequently coamplified with INT2 and HSTF1 proto-oncogenes in human breast cancers.
Saint-Ruf C; Malfoy B; Scholl S; Zafrani B; Dutrillaux B
Oncogene; 1991 Mar; 6(3):403-6. PubMed ID: 1826346
[TBL] [Abstract][Full Text] [Related]
10. BCL-1 participates in the 11q13 amplification found in breast cancer.
Theillet C; Adnane J; Szepetowski P; Simon MP; Jeanteur P; Birnbaum D; Gaudray P
Oncogene; 1990 Jan; 5(1):147-9. PubMed ID: 2181375
[TBL] [Abstract][Full Text] [Related]
11. Mapping of DNA amplifications at 15 chromosomal localizations in 1875 breast tumors: definition of phenotypic groups.
Courjal F; Cuny M; Simony-Lafontaine J; Louason G; Speiser P; Zeillinger R; Rodriguez C; Theillet C
Cancer Res; 1997 Oct; 57(19):4360-7. PubMed ID: 9331099
[TBL] [Abstract][Full Text] [Related]
12. Oncogene amplification correlates with dense lymphocyte infiltration in human breast cancers: a role for hematopoietic growth factor release by tumor cells?
Tang RP; Kacinski B; Validire P; Beuvon F; Sastre X; Benoit P; dela Rochefordière A; Mosseri V; Pouillart P; Scholl S
J Cell Biochem; 1990 Nov; 44(3):189-98. PubMed ID: 1980125
[TBL] [Abstract][Full Text] [Related]
13. D11S287, a putative oncogene on chromosome 11q13, is amplified and expressed in squamous cell and mammary carcinomas and linked to BCL-1.
Lammie GA; Fantl V; Smith R; Schuuring E; Brookes S; Michalides R; Dickson C; Arnold A; Peters G
Oncogene; 1991 Mar; 6(3):439-44. PubMed ID: 2011398
[TBL] [Abstract][Full Text] [Related]
14. Cyclin DI amplification is not associated with reduced overall survival in primary breast cancer but may predict early relapse in patients with features of good prognosis.
Seshadri R; Lee CS; Hui R; McCaul K; Horsfall DJ; Sutherland RL
Clin Cancer Res; 1996 Jul; 2(7):1177-84. PubMed ID: 9816285
[TBL] [Abstract][Full Text] [Related]
15. HER-2 amplification, steroid receptors and epidermal growth factor receptor in primary breast cancer.
Zeillinger R; Kury F; Czerwenka K; Kubista E; Sliutz G; Knogler W; Huber J; Zielinski C; Reiner G; Jakesz R
Oncogene; 1989 Jan; 4(1):109-14. PubMed ID: 2915900
[TBL] [Abstract][Full Text] [Related]
16. DNA amplification at 11q13.5-q14 in human breast cancer.
Szepetowski P; Ollendorff V; Grosgeorge J; Courseaux A; Birnbaum D; Theillet C; Gaudray P
Oncogene; 1992 Dec; 7(12):2513-7. PubMed ID: 1461654
[TBL] [Abstract][Full Text] [Related]
17. In breast cancer, amplification of the steroid receptor coactivator gene AIB1 is correlated with estrogen and progesterone receptor positivity.
Bautista S; Vallès H; Walker RL; Anzick S; Zeillinger R; Meltzer P; Theillet C
Clin Cancer Res; 1998 Dec; 4(12):2925-9. PubMed ID: 9865902
[TBL] [Abstract][Full Text] [Related]
18. Expression of fibroblast growth factor receptors flg and bek during hepatic ontogenesis and regeneration in the rat.
Hu Z; Evarts RP; Fujio K; Marsden ER; Thorgeirsson SS
Cell Growth Differ; 1995 Aug; 6(8):1019-25. PubMed ID: 8547216
[TBL] [Abstract][Full Text] [Related]
19. EMS1 amplification can occur independently of CCND1 or INT-2 amplification at 11q13 and may identify different phenotypes in primary breast cancer.
Hui R; Campbell DH; Lee CS; McCaul K; Horsfall DJ; Musgrove EA; Daly RJ; Seshadri R; Sutherland RL
Oncogene; 1997 Sep; 15(13):1617-23. PubMed ID: 9380415
[TBL] [Abstract][Full Text] [Related]
20. The human breast carcinoma cell line SW 613-S: an experimental system to study tumor heterogeneity in relation to c-myc amplification, growth factor production and other markers (review).
Lavialle C; Modjtahedi N; Lamonerie T; Frebourg T; Landin RM; Fossar N; Lhomond G; Cassingena R; Brison O
Anticancer Res; 1989; 9(5):1265-79. PubMed ID: 2686529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]